Edwards Lifesciences (EW): The Medical Device Leader Behind the TAVR Boom
Aristotle Capital Management, LLC, an investment management company, released its "Value Equity Fund" Q2 2026 investor letter. A copy of the letter can be downloaded here.
Edwards Lifesciences Corp (EW)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sivik Global Healthcare Krishen Sud | 45,000 | $3,884,400 | +125% | 2.22% |
| 2. | Bailard Inc Thomas Bailard | 16,665 | $1,438,545 | +8% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $85.74 | 580 | $49,752.72 | 3,268 | 2024-05-06 | Filing | |
| $112.23 | 1,500 | $168,345.00 | 63,811 | 2021-11-24 | Filing | |
| $90.10 | 3,000 | $270,300.00 | 9,042 | 2017-02-03 | Filing | |
| $83.33 | 3,942 | $328,486.86 | 3,942 | 2016-11-30 | Filing | |
| $83.47 | 8,928 | $745,205.88 | 43,690 | 2016-11-30 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $85.65 | 619 | $53,017.35 | 40,034 | 2026-10-08 | Filing | |
| $87.51 | 619 | $54,168.69 | 40,034 | 2026-09-11 | Filing | |
| $91.06 | 544 | $49,533.92 | 14,868 | 2026-08-31 | Filing | |
| $89.98 | 2,644 | $237,907.12 | 17,984 | 2026-08-28 | Filing | |
| $90.99 | 30,646 | $2,788,546.96 | 44,324 | 2026-08-26 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,943,675 | $1,030,978,043 | 2.27% | |
| 2. | 2,719,271 | $234,727,473 | 0.23% | |
| 3. | 963,362 | $83,157,408 | 0.25% | |
| 4. | 723,022 | $62,411,259 | 2.57% | |
| 5. | 589,732 | $50,905,666 | 6.6% |
News See All
Edwards Lifesciences (EW) Has a Growth Runway Competitors May Struggle to Match
Baron Capital, an investment management company, released its Q2 2026 investor letter for the “Baron Health Care Fund”. A copy of the letter is available to download here.
Edwards Lifesciences (EW)'s TMTT Revenue Surges 47%: Can Rapid Growth Drive the Next Leg of Earnings Expansion?
On July 23, Edwards Lifesciences Corporation (NYSE:EW) delivered second-quarter 2026 net sales of $1.74 billion, up 13.6% year over year (12.5% on a constant currency basis), surpassing Wall Street expectations...
Edwards Lifesciences (EW) is Benefitting from Expanding Its Aortic Valve Franchise
Artisan Partners, an investment management company, released its first-quarter 2026 investor letter for the “Artisan Mid Cap Fund”. A copy of the letter is available to download here.
Barclays Lifts PT on Edwards Lifesciences Corporation (EW) Following Q1 Earnings
Edwards Lifesciences Corporation (NYSE:EW) is one of the best medical device stocks to invest in right now.
10 Best Medical Device Stocks to Invest In Right Now
In this article, we will look at the 10 Best Medical Device Stocks to Invest In Right Now.
Is Edwards Lifesciences Corporation (EW) A Good Stock To Buy Now?
Is EW a good stock to buy? We came across a bullish thesis on Edwards Lifesciences Corporation Torre Financial Newsletter’s Substack by Federico Torre.
Here is Why Edwards Lifesciences Corporation (EW) Looks Attractive
Edwards Lifesciences Corporation (NYSE:EW) is one of the 10 best healthcare equipment stocks to buy according to hedge funds.
10 Best Healthcare Equipment Stocks to Buy According to Hedge Funds
The Healthcare Equipment segment is one of the areas across the broader healthcare landscape that carries immense innovation prospects and also offers a defensive play.
Edwards Lifesciences Corporation (EW) Draws Positive Analyst View After Q4 Update
Edwards Lifesciences Corporation (NYSE:EW) is one of the best medical technology stocks to invest in.
Hedge Fund Resource Center